Delhi floats global tender for 1 crore Covid-19 vaccines on urgent basis

Delhi floats global tender for 1 crore Covid-19 vaccines on urgent basis Screen grab of Delhi CM Arvind Kejriwal addressing media

New Delhi: Arvind Kejriwal government has floated a global tender to procure one crore COVID-19 doses on an urgent basis on Friday. The Delhi government has floated a Global Expression of Interest (EOI) for Covid-19 vaccines.

In the EOI, the Directorate General of Health Services (DGHS) stated that the offered vaccine must be duly approved by a competent authority of the government of India.

The Delhi government will accept an offer or expression of interest through e-mail by 5 pm on June 7. The efforts are part of efforts to ramp up the vaccination drive against Covid-19. The third phase of vaccinations, which is to inoculate people between 18-44 years of age, has been put on hold for the last five days after the state government ran out of Covid-19 doses.

Also Read: NEERI develops new and faster method of Covid sample collection for RT-PCR test

The stock of Bharat Biotech’s Covaxin has been completely exhausted in Delhi. It is not even available with the Delhi government for people aged 45 years and above.

“Delhi needs 1.84 crore COVID-19 vaccine doses to inoculate 92 lakh people in 18-44 age group,” Deputy CM Manish Sisodia said on Saturday.

“The Health and Family Welfare Department of NCT of Delhi intends to procure SARS-Cov2 vaccine on an urgent basis to control and manage the spread of the COVID-19 pandemic. Global Expression of Interest is hereby invited from international manufacturers of COVID-19 vaccine or their authorised agents or from direct importers with appropriate license to import the vaccine in India. The offered COVID-19 vaccine must be duly approved by the competent authority of the government of India,” the EOI document said.

Earlier, Pfizer and Moderna had refused to sell their vaccines directly to the Delhi and the Punjab government stating that they will only deal with the Central government.

“We have spoken to Pfizer and Moderna for vaccines, and both the companies have refused to sell vaccines directly to us. They have said that they will deal with the Government of India alone,” Delhi Chief Minister Arvind Kejriwal had said.

Read More: Delhi reports 900 cases in 24 hours, lowest in second wave: CM Kejriwal

The central government has so far approved three vaccines for use in India — Covishield, Covaxin and Russia’s Sputnik V.

The Serum Institute of India (SII) makes Covishield (under license from AstraZeneca), while Bharat Biotech makes the indigenously-developed Covaxin.

According to the Delhi government, as many as 2,65,010 doses of Covishield are available with the state government for health care workers, frontline workers and those above 45 years of age. Delhi has so far vaccinated 52,64,232 people and is left with 2,65,010 doses of Covishield for health care workers, frontline workers and those above 45 years of age.

(With ANI Inputs)

WATCH

For the latest News, Breaking News, Top News, like us on Facebook or follow us on Twitter and YouTube